ME Therapeutics Holdings Inc.
METXF
$2.95
$0.000.00%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.93% | 2.45% | 39.49% | 236.63% | 131.98% |
| Total Receivables | 303.25% | 155.21% | 186.44% | -16.67% | 132.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.86% | 816.00% | 615.25% | 40.98% | 46.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -4.10% | 5.32% | 43.74% | 195.82% | 129.77% |
|
|
|||||
| Total Current Assets | -4.10% | 5.32% | 43.74% | 195.82% | 129.77% |
| Net Property, Plant & Equipment | 179,300.00% | 165,900.00% | 170,000.00% | 79,700.00% | 0.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 12.32% | 19.50% | 61.41% | 220.99% | 129.74% |
|
|
|||||
| Total Accounts Payable | 230.41% | 229.70% | -- | 135.90% | -56.60% |
| Total Accrued Expenses | -13.71% | -10.28% | -- | 2,190.00% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 29.15% | -- |
| Total Finance Division Other Current Liabilities | -- | 296.30% | -- | -- | -- |
| Total Other Current Liabilities | -- | 296.30% | -- | -- | -- |
| Total Current Liabilities | 283.26% | 207.58% | -- | 116.58% | -57.52% |
|
|
|||||
| Total Current Liabilities | 283.26% | 207.58% | -- | 116.58% | -57.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 300.21% | 264.72% | -- | 187.39% | -57.52% |
|
|
|||||
| Common Stock & APIC | 38.06% | 39.40% | 77.28% | 30.89% | 35.52% |
| Retained Earnings | -11.96% | -13.26% | -9.98% | -12.88% | -18.25% |
| Treasury Stock & Other | -33.45% | -29.86% | -45.20% | 13.70% | 20.72% |
| Total Common Equity | 0.05% | 12.44% | 51.39% | 227.72% | 182.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.05% | 12.44% | 51.39% | 227.72% | 182.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.05% | 12.44% | 51.39% | 227.72% | 182.88% |
|
|
|||||